• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

New Ontario study finds even one COVID-19 vaccine dose provides strong protection against variants

Shiloh

Editor, Senior Moderator
Source: https://www.cp24.com/news/new-ontar...-strong-protection-against-variants-1.5496914

New Ontario study finds even one COVID-19 vaccine dose provides strong protection against variants
Chris Herhalt, Web Content Writer, CP24
Published Monday, July 5, 2021 12:08PM EDT
Last Updated Monday, July 5, 2021 12:08PM EDT

A new study of Ontario COVID-19 data finds all vaccines approved for use in Canada are doing better than first expected at preventing symptomatic infection, hospitalization or death from coronavirus variants of concern, even after just one dose.

The pre-print study published on Saturday shows one dose of the Pfizer, Moderna or AstraZeneca COVID-19 vaccines had between a 48 to 83 per cent effectiveness against symptomatic infection by any of the four variants of concern detected in Ontario recipients this past winter in spring.

Each of the vaccines also had a 78 to 96 per cent efficacy against preventing hospitalization or death from infection by a variant of concern, two weeks after a first dose...
 
Back
Top